BioCentury
ARTICLE | Clinical News

Avant reports Phase IIb cholera data

May 8, 2001 7:00 AM UTC

AVAN said that in a double-blind Phase IIb study of its Peru-15 oral cholera vaccine in 59 healthy volunteers, the product gave 100% protection against moderate and severe diarrhea following challenge...